Mupirocin Calcium Cream, 2% + Bactroban® Cream + Cream vehicle of test product
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Secondarily Infected Traumatic Skin Lesions
Conditions
Secondarily Infected Traumatic Skin Lesions
Trial Timeline
Feb 1, 2013 → May 6, 2019
NCT ID
NCT01876550About Mupirocin Calcium Cream, 2% + Bactroban® Cream + Cream vehicle of test product
Mupirocin Calcium Cream, 2% + Bactroban® Cream + Cream vehicle of test product is a phase 1 stage product being developed by Sun Pharmaceutical for Secondarily Infected Traumatic Skin Lesions. The current trial status is completed. This product is registered under clinical trial identifier NCT01876550. Target conditions include Secondarily Infected Traumatic Skin Lesions.
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01876550 | Phase 1 | Completed |